|
 |
Environment > Secondary Treatment
The following information is about Secondary Treatment.
Secondary Treatment Defined
The second step in most publicly owned waste treatment systems in which bacteria consume the organic parts of the waste. It is accomplished by bringing together waste, bacteria, and oxygen in trickling filters or in the activated sludge process. This treatment removes floating and settleable solids and about 90 percent of the oxygen-demanding substances and suspended solids. Disinfection is the final stage of secondary treatment. (See
This definition is in context to Environment. See more contextual defintions for Secondary Treatment.
Nearly Half of Americans Won't Flee Without Fido
Published September 5, 2008, 1:19 pm, PR Newswire via Yahoo! Finance
A 2007 survey by the American Humane Association found that 47 percent of Americans would refuse rescue assistance if it meant leaving without their family pet. With Hurricanes Hanna, Ike and Josephine moving towards the U.S. coast, residents and officials should begin properly planning for their pets' care during an evacuation.
Blacks Less Likely Than Whites To Receive Standard Of Care In Radiation Therapy For Breast Cancer
Published September 5, 2008, 7:15 am, Medical News Today
Black women are less likely than white women to receive radiation therapy after a lumpectomy, the standard of care for early stage breast cancer, according to a new study by researchers at The University of Texas M. D. Anderson Cancer Center.
QuatRx Initiates Second Phase 3 Study Of Ophena(TM) (Ospemifene Tablets) In Women With Postmenopausal Vaginal Syndrome
Published September 5, 2008, 7:14 am, Medical News Today
QuatRx Pharmaceuticals, a privately-held biopharmaceutical company focused on development and commercialization of compounds to treat endocrine, metabolic and cardiovascular disorders, announced that it has initiated a second Phase 3 clinical trial of Ophena(TM) (ospemifene tablets), the com
BioCryst Reports Results From BCX-4208 Phase IIa Trial In Subjects With Psoriasis
Published September 5, 2008, 7:14 am, Medical News Today
BioCryst Pharmaceuticals (Nasdaq: BCRX) announced results from the completed Phase IIa trial of BCX-4208 in patients with moderate to severe plaque psoriasis.
Editors Memo
Published September 5, 2008, 6:34 am, BioMechanics
Does dark matter cause ACL injuries? I see two types of dark matter on our radar. One is quite exciting, at least to this former astronomy major, and one is potentially catastrophic.
Koinonia alumni celebrate new life
Published September 5, 2008, 5:23 am, The Rhinelander Daily News
When Jim St. Charles left his 45-day recovery program at Koinonia Treatment Center in January, he did not know how he would cope with returning to a world he had only known as an addict. What St. Charles has found in the past eight months is that the best way to re-enter the world after treatment is to build friendships with people who have been through the same struggle.
Major Bleeding Has Significant Impact And Contributes To 30-Day Mortality Following Angioplasty In Severe Heart Attack ...
Published September 5, 2008, 4:16 am, Medical News Today
The Medicines Company (NASDAQ: MDCO) announced the presentation of a new analysis of data from the HORIZONS-AMI trial demonstrating that major bleeding contributes to more deaths at 30 days than repeat heart attack, or re-infarction, in severe heart attack patients treated with angioplasty.
Cytopia Commences Second Phase II Study In Brain Cancer
Published September 5, 2008, 3:14 am, Medical News Today
Cytopia Limited (ASX:CYT) announced that it is commencing enrolment for its Phase Ib/II study of CYT997, the company's novel vascular-disrupting anticancer agent, in patients with an aggressive form of brain cancer known as glioblastoma multiforme (GBM).
Profitable Pollution
Published September 4, 2008, 11:39 pm, Zawya
The thick clouds of pollution hanging over Cairo might suggest that cleaning up is the last thing on the program for Egyptian industry.
Racial Disparities Found In Radiation Therapy Rates For Breast Cancer
Published September 4, 2008, 7:20 pm, Science Daily
African-American women are less likely than white women to receive radiation therapy after a lumpectomy, the standard of care for early stage breast cancer, according to a new study by researchers at The University of Texas M. D. Anderson Cancer Center.
Are you looking for additional Environment > Secondary Treatment news? Try our new "Secondary Treatment News Focus" area.
Off-site Secondary Treatment Links, User Submitted
The following links have been collected through user bookmark submission in the Secondary Treatment category. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.
Sat Feb 23
- treatment for secondary liver cancer: treatment for secondary liver cancer
Sat Feb 16
If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > Secondary Treatment. If you would like to find related tags we recommend Tag Patterns > Secondary Treatment
Off-site Secondary Treatment Research Links
If you still need additional information on Secondary Treatment then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.
- A9 > Secondary Treatment
- Alexa > Secondary Treatment
- Anti-Aging Revolution > Secondary Treatment
- DMOZ > Secondary Treatment
- Feeds Filtered > Secondary Treatment
- Google > Secondary Treatment
- News Meme > Secondary Treatment
- Nuah: News > Secondary Treatment
- The Feed Directory > Secondary Treatment
- OBP > Secondary Treatment
- Open Tag Directory > Secondary Treatment
- Podzy > Secondary Treatment
- Yahoo > Secondary Treatment
Environment Topics
Everything you need to know about Environment
Environment
If you know the Environment Term Name use the links below to quickly jump to your desired focus.
Bookmark Us
The On Topic Network
This website is part of The On Topic Network.
Thank You
Environment.On-Topic.net was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.
Best Viewed With
License
This work is licensed under Creative Commons.